Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 101

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 101
---
 transferred a total of 4,320,000 Class A Ordinary Shares and 480,000 Class B Ordinary  
 Shares to several individuals and entities at $1.2 per share, representing 48% of total ordinary shares on an as converted basis   
 of the Company prior to the completion of this offering. Following this, on February 5, 2025, one of these individual shareholders 
 holding 480,000 Class A Ordinary Shares, representing 4.8% of total ordinary shares on an as converted basis, transferred his      
 holding to another of these individual shareholders. See “Principal Shareholder” on page 106 of this prospectus for                
 details.                                                                                                                           |

<div align='center'>55</div>

The Company, together with its wholly-owned
subsidiaries, is effectively controlled by the same shareholder, Mr. To, at 100% before the Reorganization and ultimately held as to
52% after the Reorganization. As such, the Reorganization is considered as a recapitalization of entities under common control. The Company
has retroactively restated all shares and per share data for all the periods presented.

In accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805-50-25, the Reorganization has been accounted for as a recapitalization among entities under common control since the same shareholder controlled all these entities prior to and after the Reorganization. The consolidation of the Company and its subsidiaries has been accounted for at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the first period presented in the accompanying consolidated financial statements. The results of operations for the period presented comprise those of the previously separate entities combined from the beginning of the period to the end of the period. By eliminating the effects of intra-entity transactions in determining the results of operations for the period before the Reorganization, those results will be substantially the same as the results of operations for the period after the date of Reorganization.

We started our business in Hong Kong in 1994 and have been focusing on promotion of homeopathy, and sales, marketing and distribution of quality homeopathic products for public health. We are a homeopathic products supplier in Hong Kong’s active homeopathic products market in terms of number of sales and profitability, according to Frost & Sullivan.

The global rise in health consciousness has
fueled a growing demand for natural, holistic healing approaches. This has led to a surge in the popularity of homeopathic remedies in